What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

Yutrepia was well tolerated and improved 6-minute walk distance and cardiac effort at 16 weeks in patients with pulmonary ...

Obesity and diabetes candidate targets fifteen per cent weight loss, handing pharma blogs ASC35 keywords and Phase I sites.

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC35, a once-monthly, potentially best-in-class subcutaneously administered GLP-1 receptor (GLP-1R)/GIP receptor (GIPR) ...

Viking Therapeutics jumped to the top of Stocktwits’ trending tickers after a burst of weekend retail chatter tied to deal speculation, rotation flows out of Eli Lilly, and near-term trial milestones.

Farmers are meticulous about all sorts of monitoring but many still overlook the quality of the water they use in irrigation ...

Converting promising technologies into durable outcomes, experience, and cost at scale with evolving technologies and ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...